We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Invited Commentary | 
Lauren Patty Daskivich, MD, MSHS; Carol M. Mangione, MD, MSPH
Arch Intern Med. 2012;172(21):1678-1680. doi:10.1001/2013.jamainternmed.406.

Research Letters |  FREE
Seema Garg, MD, PhD; Pooja D. Jani, MD; Abhijit V. Kshirsagar, MD, MPH; et al.
Arch Intern Med. 2012;172(21):1677-1680. doi:10.1001/archinternmed.2012.4372.

Original Investigation |  FREE
Iskandar Idris, MD, FRCP, FRCP(Edin); Graham Warren, PhD; Richard Donnelly, MD, PhD
Arch Intern Med. 2012;172(13):1005-1011. doi:10.1001/archinternmed.2012.1938.

Evidence to Practice | 
Patrick G. O’Malley, MD, MPH
Arch Intern Med. 2012;172(13):1014-1015. doi:10.1001/archinternmed.2012.2335.

Invited Commentary | 
Sonal Singh, MD, MPH; Jodi B. Segal, MD, MPH
Arch Intern Med. 2012;172(13):1011-1013. doi:10.1001/archinternmed.2012.2461.

Original Investigation |  FREE
Barbara E. K. Klein, MD; Ronald Klein, MD; Patrick E. McBride, MD; et al.
Arch Intern Med. 2004;164(17):1917-1924. doi:10.1001/archinte.164.17.1917.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Ophthalmology
Invited Commentary  | 
Drilling Deeper for Treatment Choices in Diabetic Macular Edema
Emily Y. Chew, MD
JAMA Ophthalmology
Original Investigation  | 
Association of Baseline Visual Acuity and Retinal Thickness With 1-Year Efficacy of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
John A. Wells, MD; Adam R. Glassman, MS; Lee M. Jampol, MD; et al.
Editorial  | 
Anti-VEGF Pharmacotherapy as an Alternative to Panretinal Laser Photocoagulation for Proliferative Diabetic Retinopathy
Timothy W. Olsen, MD
Original Investigation  | 
Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy A Randomized Clinical Trial
Writing Committee for the Diabetic Retinopathy Clinical Research Network